论文部分内容阅读
目的:探索方便、安全、有效预防产后出血方法。方法:选择足月阴道分娩产妇300例,随机分米索前列醇(A组)、催产素(B组)、米索前列醇+催产素(C组)。A组胎儿娩出后给米索前列醇0.6 mg,肛门外用;B组胎头娩出后,即刻静脉点滴催产素20单位;C组胎儿娩出后静脉点滴催产素20 U+米索前列醇0.6 mg肛门外用。观察第三产程时间,产后2 h出血量。结果:第三产程时间B组、C组明显短于A组,产后2 h出血量A组、C组明显少于B组。结论:米索前列醇0.6 mg肛用+静点催产素20 U能有效预防产后出血。
Objective: To explore a convenient, safe and effective way to prevent postpartum hemorrhage. Methods: 300 full-term vaginal delivery women were selected and randomized to receive misoprostol (group A), oxytocin (group B), misoprostol + oxytocin (group C). A group of fetuses delivered to misoprostol 0.6 mg, anal for external use; Group B fetal head immediately after the delivery of intravenous oxytocin 20 units; C group of fetus after delivery intravenous oxytocin 20 U + misoprostol 0.6 mg anal for external use . Observe the third stage of labor time, 2 h postpartum hemorrhage. Results: The time of the third stage of labor was significantly shorter in group B and group C than in group A, and the amount of hemorrhage in group A was less than group B at 2 h after delivery. Conclusion: Misoprostol 0.6 mg anal + intravenous oxytocin 20 U can effectively prevent postpartum hemorrhage.